Setup News Ticker
Searching for 'vaccine variant'. (Return)

CBC Top StoriesJan 25, 2022
Pfizer-BioNTech launch trial of Omicron-targeted COVID-19 vaccine
Pfizer and BioNTech said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen.

  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2022 CEOExpress Company LLC